跳至主要内容
临床试验/NCT02039206
NCT02039206已完成2 期

The Influence of Deep Repetitive Transcranial Magnetic Stimulation (TMS) on Cerebellar Signs in Patients With Spinocerebellar Ataxia Type 3 (SCA3 - Machado Joseph Disease)

Brainsway1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年2月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
Brainsway
入组人数
20
试验地点
1
主要终点
Scale for the Assessment and Rating of Ataxia (SARA)

研究概览

简要总结

To test the effects of low frequency deep rTMS using the novel HCERMJD-coil on cerebellar deficits in patients with SCA3 and to establish its safety in this population.

Investigator is anticipate that stimulation of the cerebellum with the novel HCERMJD-coil may induce significantly therapeutic effects in patients with SCA3 and will pave the way for establishing a novel and effective treatment for this disorder.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SCA3 patients aged 20 - 80 years, with detectable clinical signs and confirmed genetic diagnosis.

排除标准

  • Patients who have concomitant epilepsy.
  • History of seizure or heat convulsion.
  • Patients on neuroleptics.
  • Patients with dementia (MMSE<25) or any unstable medical disorder.
  • History or current unstable hypertension.
  • History of head injury or neurosurgical interventions.
  • History of any metal in the head (outside the mouth).
  • Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps.
  • History of frequent or severe headaches.
  • History of migraine.
  • History of hearing loss.
  • History of cochlear implants
  • History of drug abuse or alcoholism.
  • Pregnancy or not using a reliable method of birth control.
  • Participation in current clinical study or clinical study within 30 days prior to this study.

研究组 & 干预措施

Treatment

Experimental

Deep TMS

干预措施: Deep TMS (Device)

结局指标

主要结局

Scale for the Assessment and Rating of Ataxia (SARA)

时间窗: 30 days

次要结局

未报告次要终点

研究者

发起方
Brainsway
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验